FR2264555B1 - - Google Patents

Info

Publication number
FR2264555B1
FR2264555B1 FR7508548A FR7508548A FR2264555B1 FR 2264555 B1 FR2264555 B1 FR 2264555B1 FR 7508548 A FR7508548 A FR 7508548A FR 7508548 A FR7508548 A FR 7508548A FR 2264555 B1 FR2264555 B1 FR 2264555B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7508548A
Other versions
FR2264555A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmaceutici Italia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmaceutici Italia SpA filed Critical Farmaceutici Italia SpA
Publication of FR2264555A1 publication Critical patent/FR2264555A1/fr
Application granted granted Critical
Publication of FR2264555B1 publication Critical patent/FR2264555B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
FR7508548A 1974-03-22 1975-03-19 Expired FR2264555B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1278374A GB1457632A (en) 1974-03-22 1974-03-22 Adriamycins

Publications (2)

Publication Number Publication Date
FR2264555A1 FR2264555A1 (fr) 1975-10-17
FR2264555B1 true FR2264555B1 (fr) 1980-01-11

Family

ID=10011048

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7508548A Expired FR2264555B1 (fr) 1974-03-22 1975-03-19

Country Status (18)

Country Link
US (1) US4058519A (fr)
JP (1) JPS5840555B2 (fr)
AT (1) AT338420B (fr)
AU (1) AU497500B2 (fr)
BE (1) BE826978A (fr)
CA (1) CA1046507A (fr)
CH (1) CH612947A5 (fr)
DE (1) DE2510866C3 (fr)
DK (1) DK153158C (fr)
ES (1) ES435833A1 (fr)
FR (1) FR2264555B1 (fr)
GB (1) GB1457632A (fr)
HK (1) HK882A (fr)
MY (1) MY103912A (fr)
NL (1) NL176635C (fr)
SE (1) SE434844B (fr)
SU (1) SU583763A3 (fr)
ZA (1) ZA751781B (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133877A (en) * 1976-07-08 1979-01-09 Societa Farmaceutici Italia S.P.A. Anthracycline ethers and use therefor
US4201773A (en) * 1978-07-26 1980-05-06 The United States Of America As Represented By The Department Of Health, Education And Welfare 7-O-(2,6-Dideoxy-α-L-lyxo-hexopyranosyl)-daunomycinone, desmethoxy daunomycinone, adriamycinone, and carminomycinone
US4345068A (en) * 1979-11-22 1982-08-17 Farmitalia Carlo Erba S.P.A. Process for the preparation of 4'-epidaunorubicin, 3',4'-diepidaunorubicin, their doxorubicin analogs, and intermediates used in said process
EP0051280B1 (fr) * 1980-11-01 1984-07-11 FARMITALIA CARLO ERBA S.p.A. Dérivés glycosidiques d'anthracyclines, méthode pour leur préparation, dérivés intermédiaires et leur préparation et compositions pharmaceutiques
US4393052A (en) * 1980-11-01 1983-07-12 Farmitalia Carlo Erba S.P.A. Antitumor anthracycline glycosides, their preparation, intermediates therefor, and compositions and use thereof
US4562177A (en) * 1982-08-17 1985-12-31 The Ohio State University Research Foundation 3'-Amino-2' halo-anthracycline antibiotics
US4537882A (en) * 1984-05-10 1985-08-27 Ohio State University 4-Demethoxy-3'-desamino-2'-halo-anthracycline and pharmaceutical composition containing same
DE3500029A1 (de) * 1985-01-02 1986-09-04 Farmitalia Carlo Erba S.p.A., Mailand/Milano Anthracyclinester
GB2169284A (en) * 1985-01-05 1986-07-09 Erba Farmitalia 4'-Epidoxorubicin-14-esters
JPS61172891A (ja) * 1985-01-24 1986-08-04 フア−ミタリア・カルロ・エルバ・ソシエタ・ペル・アツイオ−ニ アントラサイクリン類エステルの製法
US5977082A (en) * 1985-08-02 1999-11-02 Pharmacia & Upjohn Company Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5124318A (en) * 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.R.L. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5124317A (en) 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.P.A. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
GB8519452D0 (en) * 1985-08-02 1985-09-11 Erba Farmitalia Injectable solutions
JPH034367Y2 (fr) * 1986-05-20 1991-02-05
DE69609845T2 (de) 1996-12-16 2000-12-21 Pharmachemie Bv Verfahren zur Herstellung von Epirubicin oder Zusatzsalzen davon, von Daunorubicin
ES2235518T3 (es) * 1998-10-16 2005-07-01 Mercian Corporation Cristalizacion de hidrocloruro de doxorubicina.
KR100785966B1 (ko) * 2000-08-10 2007-12-14 동아제약주식회사 안트라싸이클린계 항암제인 에피루비신 및 약학적으로허용되는 그 염의 제조방법
KR100850408B1 (ko) * 2000-08-10 2008-08-04 동아제약주식회사 안트라싸이클린계 항암제인 에피루비신 및 약학적으로허용되는 그 염의 제조방법
US20080161251A1 (en) 2005-01-21 2008-07-03 Astex Therapeutics Limited Pharmaceutical Compounds
PL375008A1 (pl) 2005-05-12 2006-11-13 Institut National De La Sante Et De La Recherche Medicale, Inserm Nowe zastosowanie medyczne chlorowodorku epirubicyny
US8916552B2 (en) 2006-10-12 2014-12-23 Astex Therapeutics Limited Pharmaceutical combinations
US8883790B2 (en) 2006-10-12 2014-11-11 Astex Therapeutics Limited Pharmaceutical combinations
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
CA2748034A1 (fr) 2008-12-23 2010-07-01 Pharmasset, Inc. Promedicaments de 2'-deoxy'2'-fluoro-2'-c-methyl-nucleoside-phosphoramidate purifie destines au traitement d'infections virales
CN102325783A (zh) 2008-12-23 2012-01-18 法莫赛特股份有限公司 嘌呤核苷的合成
PA8855601A1 (es) 2008-12-23 2010-07-27 Forformidatos de nucleósidos
SG184323A1 (en) 2010-03-31 2012-11-29 Gilead Pharmasett Llc Stereoselective synthesis of phosphorus containing actives
CN108473523B (zh) * 2016-01-11 2022-03-15 浙江海正药业股份有限公司 一种盐酸表柔比星的制备方法及其中间体
SG11201807965YA (en) 2016-03-15 2018-10-30 Oryzon Genomics Sa Combinations of lsd1 inhibitors for use in the treatment of solid tumors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3356674A (en) * 1961-07-07 1967-12-05 Rikagaku Kenkyusho 3-c-hydroxymethyl-3, 5-didesoxy-l-lyxofuranose and its derivatives, and a process for the production thereof
US3427300A (en) * 1965-11-12 1969-02-11 Merck & Co Inc Anti-inflammatory steroid 2'-acetamido-2'-deoxy-glucoside compounds
YU33730B (en) * 1967-04-18 1978-02-28 Farmaceutici Italia Process for preparing a novel antibiotic substance and salts thereof
US3803124A (en) * 1968-04-12 1974-04-09 Farmaceutici It Soc Process for the preparation of adriamycin and adriamycinone and adriamycin derivatives
US3629231A (en) * 1968-05-23 1971-12-21 Biorex Laboratories Ltd Derivatives of glycyrrhetinic acid
US3651090A (en) * 1969-12-17 1972-03-21 Cutter Lab 1 3-dioxolan-4-yl-alkyl guanidines
FR2183710A1 (en) * 1972-05-06 1973-12-21 Farmaceutici Italia Daunomycin (hydrochloride) prepn - by reaction of daunomycinone with daunosamines, useful as antitumour agent and anti-leucemic

Also Published As

Publication number Publication date
SE434844B (sv) 1984-08-20
FR2264555A1 (fr) 1975-10-17
HK882A (en) 1982-01-22
NL176635B (nl) 1984-12-17
DK114475A (fr) 1975-09-23
DE2510866A1 (de) 1975-10-02
DK153158C (da) 1989-01-16
AU497500B2 (en) 1978-12-14
SU583763A3 (ru) 1977-12-05
US4058519A (en) 1977-11-15
DE2510866B2 (de) 1979-12-06
CH612947A5 (fr) 1979-08-31
JPS5840555B2 (ja) 1983-09-06
ZA751781B (en) 1976-02-25
NL7502934A (nl) 1975-09-24
SE7503215L (fr) 1975-09-23
ATA207475A (de) 1976-12-15
DE2510866C3 (de) 1980-08-14
NL176635C (nl) 1985-05-17
CA1046507A (fr) 1979-01-16
BE826978A (fr) 1975-09-22
MY103912A (en) 1993-10-30
ES435833A1 (es) 1976-12-01
AT338420B (de) 1977-08-25
DK153158B (da) 1988-06-20
AU7926375A (en) 1976-09-23
JPS50126656A (fr) 1975-10-04
GB1457632A (en) 1976-12-08

Similar Documents

Publication Publication Date Title
FR2269203B1 (fr)
FR2264555B1 (fr)
FR2285303B1 (fr)
IN141368B (fr)
JPS5136707A (fr)
FR2268250B3 (fr)
DK109275A (fr)
FR2286801B3 (fr)
FR2257370B3 (fr)
JPS5117747Y2 (fr)
FR2292963B1 (fr)
JPS50103535A (fr)
JPS50111353A (fr)
JPS50112142U (fr)
JPS50141150U (fr)
JPS50144726U (fr)
JPS50107590U (fr)
JPS5153941U (fr)
CH583868A5 (fr)
CH1378974A4 (fr)
CH579948A5 (fr)
CH578274A5 (fr)
CH578109A5 (fr)
CH577803A5 (fr)
CH1736574A4 (fr)

Legal Events

Date Code Title Description
CD Change of name or company name
TP Transmission of property
TP Transmission of property
CC Supplementary protection certificate (spc) laid open to the public (law of 25 june 1990)

Free format text: 92C0086, 920424

CB Supplementary protection certificate (spc) granted (law of 25 june 1990)

Free format text: 92C0086, 750319

CL Concession to grant licences
CD Change of name or company name